Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BTRC 4017A |
Trade Name | |
Synonyms | BTRC4017A|RG6194|Runimotamab|BTRC-4017A |
Drug Descriptions |
BTRC 4017A is a bispecific antibody that targets both Erbb2 (Her2) and CD3, which may lead to CTL-dependent killing of Erbb2 (Her2)-expressing tumor cells (PMID: 30442682). |
DrugClasses | CD3 Antibody 99 HER2 (ERBB2) Antibody 76 |
CAS Registry Number | NA |
NCIT ID | C156705 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BTRC 4017A | BTRC 4017A | 0 | 1 |